granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change

Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 30 September 2017 2018 THB mm % THB mm % THB mm % Sale Revenue Revenue from selling product under Company’s trademark 1

–2021 Balance by Quarter Change Q2–21 Q1–21 Q2–20 Q2–21 VS Q1–21 Q2–21 VS Q2–20 (Million Baht: MB) (MB) % (MB) % Total revenue 2,081.2 1,824.2 1,187.6 257.0 14.1 893.6 75.2 Total operating expenses

does not change significantly in 2005, though the pace of growth may slow down, in line with a declining trend in global economic expansion. Various negative factors that impacted economic growth in the

CONSTRUCTION EXECUTIVE SUMMARY EXECUTIVE SUMMARY 2 Q1’19 Q4’19 Q1’20 change change Btmn Btmn Btmn y-on-y q-on-q Sales and service income 10,257 11,258 11,223 9.4% (0.3%) EBITDA* 2,413 2,938 3,278 35.8% 11.6% Net

The financial expenses in 2017 were 16.91 million baht decreased from previous year which were at 7.77 million baht. Comparing in term of percent of revenues, the ratio is not much change. It was at

Ref Ref. 2S_BoD017/2018 May 9th, 2018 Subject: Clarification of the change in operating result more than 20% To : The president The Stock Exchange of Thailand 2S Metal Public Company Limited (the

from prior year by Baht 801.9 million or 96.3% due following to: Description 2019 Million Baht 2018 Million Baht Change Million Baht Change (%) Revenue from real estate segment - 800.0 (800.0) (100.0

Ref Ref. 2S_BoD001/2020 February 26th, 2020 Subject: Clarification of the change in operating result more than 20% To : The president The Stock Exchange of Thailand 2S Metal Public Company Limited

Change Amount Change 2019 2018 Value % 2019 2018 Amount % Revenue from sale – net 1,254.18 1,393.11 -138.92 -9.97% 1,251.51 1,381.97 -130.47 -9.44% Gain on exchange rate 0.34 1.26 -0.92 -72.75% 0.41 1.29